香港股市 已收市

BrainsWay Ltd. (BWAY)

NasdaqGM - NasdaqGM 延遲價格。貨幣為 USD。
加入追蹤清單
5.33-0.12 (-2.20%)
收市:04:00PM EDT

BrainsWay Ltd.

Bynet Building
3rd Floor 19 Hartum Street Har Hotzvim
Jerusalem 9777518
Israel
972-2-582-4030
https://www.brainsway.com

版塊Healthcare
行業Medical Devices
全職員工134

高階主管

名稱頭銜支付行使價出生年份
Mr. Hadar LevyChief Executive Officer434k1974
Mr. Avner HagaiFounder & Director43.65k1956
Prof. Abraham ZangenCo-Founder, Member of Scientific Advisory Board & Director72.17k1970
Dr. Yiftach Roth Ph.D.Founder & Chief Scientific Officer108k1971
Mr. Ido MaromChief Financial Officer1976
Mr. Menachem C. Klein Esq.VP, General Counsel & Corporate Secretary
Dr. Aron TendlerChief Medical Officer
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

公司管治

截至 無 止,BrainsWay Ltd. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。